NO983333L - Kinolin-2-(1H)-on - Google Patents
Kinolin-2-(1H)-onInfo
- Publication number
- NO983333L NO983333L NO983333A NO983333A NO983333L NO 983333 L NO983333 L NO 983333L NO 983333 A NO983333 A NO 983333A NO 983333 A NO983333 A NO 983333A NO 983333 L NO983333 L NO 983333L
- Authority
- NO
- Norway
- Prior art keywords
- nr6r7
- hal
- derivatives
- relates
- salts
- Prior art date
Links
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19601782A DE19601782A1 (de) | 1996-01-19 | 1996-01-19 | Chinolin-2-(1H)one |
| PCT/EP1997/000084 WO1997026244A1 (fr) | 1996-01-19 | 1997-01-10 | Quinolein-2-(1h)-ones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983333D0 NO983333D0 (no) | 1998-07-17 |
| NO983333L true NO983333L (no) | 1998-09-18 |
Family
ID=7783141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983333A NO983333L (no) | 1996-01-19 | 1998-07-17 | Kinolin-2-(1H)-on |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6028080A (fr) |
| EP (1) | EP0885196A1 (fr) |
| JP (1) | JP2000503308A (fr) |
| KR (1) | KR19990077308A (fr) |
| CN (1) | CN1211974A (fr) |
| AR (1) | AR005646A1 (fr) |
| AU (1) | AU716230B2 (fr) |
| BR (1) | BR9707027A (fr) |
| CA (1) | CA2243474C (fr) |
| CZ (1) | CZ224098A3 (fr) |
| DE (1) | DE19601782A1 (fr) |
| HU (1) | HUP9900563A3 (fr) |
| MX (1) | MX9805700A (fr) |
| NO (1) | NO983333L (fr) |
| PL (1) | PL327829A1 (fr) |
| SK (1) | SK93198A3 (fr) |
| WO (1) | WO1997026244A1 (fr) |
| ZA (1) | ZA97364B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02004330A (es) * | 1999-11-03 | 2004-07-30 | Albany Molecular Res Inc | Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.. |
| US7273889B2 (en) * | 2002-09-25 | 2007-09-25 | Innovative Drug Delivery Systems, Inc. | NMDA receptor antagonist formulation with reduced neurotoxicity |
| US7166738B2 (en) * | 2004-04-23 | 2007-01-23 | Roche Palo Alto Llc | Non-nucleoside reverse transcriptase inhibitors |
| US7625949B2 (en) * | 2004-04-23 | 2009-12-01 | Roche Palo Alto Llc | Methods for treating retroviral infections |
| CN101291905A (zh) * | 2005-10-19 | 2008-10-22 | 弗·哈夫曼-拉罗切有限公司 | 苯乙酰胺nnrt抑制剂 |
| WO2009102893A2 (fr) * | 2008-02-14 | 2009-08-20 | Amira Pharmaceuticals, Inc. | Composés diaryliques cycliques en tant qu'antagonistes de récepteurs de prostaglandine d2 |
| JP2011513242A (ja) | 2008-02-25 | 2011-04-28 | アミラ ファーマシューティカルズ，インク． | プロスタグランジンｄ２受容体アンタゴニスト |
| EP2272822A4 (fr) | 2008-03-31 | 2012-01-18 | Renascience Co Ltd | Inhibiteur de l'inhibiteur de l'activateur du plasminogène-1 |
| US8426449B2 (en) * | 2008-04-02 | 2013-04-23 | Panmira Pharmaceuticals, Llc | Aminoalkylphenyl antagonists of prostaglandin D2 receptors |
| GB2463788B (en) * | 2008-09-29 | 2010-12-15 | Amira Pharmaceuticals Inc | Heteroaryl antagonists of prostaglandin D2 receptors |
| WO2010039977A2 (fr) | 2008-10-01 | 2010-04-08 | Amira Pharmaceuticals, Inc. | Antagonistes d’hétéroaryle des récepteurs de la prostaglandine d2 |
| US8383654B2 (en) | 2008-11-17 | 2013-02-26 | Panmira Pharmaceuticals, Llc | Heterocyclic antagonists of prostaglandin D2 receptors |
| EP2415755A4 (fr) * | 2009-03-31 | 2012-09-19 | Renascience Co Ltd | Agent inhibiteur de l'inhibiteur de l'activateur du plasminogène 1 |
| EP2521713A4 (fr) | 2010-01-06 | 2013-10-02 | Panmira Pharmaceuticals Llc | Antagoniste du dp2 et ses utilisations |
| JP5840324B2 (ja) | 2013-04-15 | 2016-01-06 | 株式会社レナサイエンス | Ｐａｉ−１阻害剤の新規用途 |
| JP2023511370A (ja) | 2020-01-22 | 2023-03-17 | シーロス セラピューティクス， インコーポレイテッド | Ｎｍｄａ拮抗薬の副作用の低減 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69113115T2 (de) * | 1990-05-31 | 1996-06-13 | Merck Sharp & Dohme | Dioxo-tetrahydrochinolinderivate. |
| US5268378A (en) * | 1990-05-31 | 1993-12-07 | Merck Sharp & Dohme, Limited | Dioxo-tetrahydroquinoline derivatives |
| GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
| GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| EP0685466A1 (fr) * | 1994-06-02 | 1995-12-06 | Ciba-Geigy Ag | Dérivés de 3-hétéroaliphatyle- et 3-(hétéro)-(aryle)-aliphatyle-2(1H)-quinolone |
-
1996
- 1996-01-19 DE DE19601782A patent/DE19601782A1/de not_active Withdrawn
-
1997
- 1997-01-10 CA CA002243474A patent/CA2243474C/fr not_active Expired - Fee Related
- 1997-01-10 BR BR9707027A patent/BR9707027A/pt unknown
- 1997-01-10 WO PCT/EP1997/000084 patent/WO1997026244A1/fr not_active Ceased
- 1997-01-10 AU AU13112/97A patent/AU716230B2/en not_active Ceased
- 1997-01-10 HU HU9900563A patent/HUP9900563A3/hu unknown
- 1997-01-10 EP EP97900586A patent/EP0885196A1/fr not_active Withdrawn
- 1997-01-10 US US09/101,837 patent/US6028080A/en not_active Expired - Fee Related
- 1997-01-10 JP JP9525656A patent/JP2000503308A/ja not_active Withdrawn
- 1997-01-10 CN CN97192395A patent/CN1211974A/zh active Pending
- 1997-01-10 CZ CZ982240A patent/CZ224098A3/cs unknown
- 1997-01-10 SK SK931-98A patent/SK93198A3/sk unknown
- 1997-01-10 KR KR1019980705454A patent/KR19990077308A/ko not_active Withdrawn
- 1997-01-10 PL PL97327829A patent/PL327829A1/xx unknown
- 1997-01-16 ZA ZA97364A patent/ZA97364B/xx unknown
- 1997-01-17 AR ARP970100184A patent/AR005646A1/es unknown
-
1998
- 1998-07-15 MX MX9805700A patent/MX9805700A/es unknown
- 1998-07-17 NO NO983333A patent/NO983333L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL327829A1 (en) | 1999-01-04 |
| ZA97364B (en) | 1997-07-22 |
| MX9805700A (es) | 1998-11-29 |
| AU716230B2 (en) | 2000-02-24 |
| US6028080A (en) | 2000-02-22 |
| SK93198A3 (en) | 1999-01-11 |
| AU1311297A (en) | 1997-08-11 |
| CZ224098A3 (cs) | 1998-10-14 |
| KR19990077308A (ko) | 1999-10-25 |
| CA2243474A1 (fr) | 1997-07-24 |
| HUP9900563A3 (en) | 2000-02-28 |
| CA2243474C (fr) | 2009-10-27 |
| EP0885196A1 (fr) | 1998-12-23 |
| CN1211974A (zh) | 1999-03-24 |
| NO983333D0 (no) | 1998-07-17 |
| WO1997026244A1 (fr) | 1997-07-24 |
| JP2000503308A (ja) | 2000-03-21 |
| BR9707027A (pt) | 1999-07-20 |
| DE19601782A1 (de) | 1997-07-24 |
| AR005646A1 (es) | 1999-07-14 |
| HUP9900563A2 (hu) | 1999-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO983333L (no) | Kinolin-2-(1H)-on | |
| MY136270A (en) | Processes and intermediates for preparing anti-cancer compounds | |
| BG102625A (en) | Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives | |
| NO931151D0 (no) | Fremgangsmaate for fremstilling av nitrogenholdige heterocykliske forbindelser med kondenserte ringer | |
| NZ298296A (en) | Imidazo[4,5-c]quinoline amines; medicaments to induce interferon biosynthesis | |
| DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
| DK69790D0 (da) | Heterocykliske forbindelser, deres fremstilling af anvendelse | |
| ZA867617B (en) | 3-vinyl-and 3-ethinyl-beta-carboline derivatives their production and their use as drugs | |
| CA2264065A1 (fr) | Derives d'acylaminoalkenylene comme antagonistes de nk1 et nk2 | |
| FI99014B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bentsotieno[2,3-b]pyratsiini-2,3(1H,4H)-dionien valmistamiseksi | |
| MXPA03005334A (es) | Derivados de aminotriazolopiridina como ligandos del receptor de adenosina. | |
| PT70740B (pt) | Derivate des 2-hydroxy-naphtalins und ihre verwendung als kupplingskomponente in diazotypiematerialen | |
| BG106937A (en) | Novel indole derivatives | |
| WO2000024717A3 (fr) | Composes | |
| NZ333229A (fr) | ||
| FI915025A0 (fi) | 8-azabicyklo(3,2,1) oktylalkyltiazolidinoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| GR82272B (fr) | ||
| SE9300976L (fr) | ||
| DE69501810D1 (de) | Verwendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie | |
| MX9701547A (es) | Compuestos siloxi asimetricos. | |
| DE59809929D1 (de) | 6-substituierte 1,2,4a,5a,8a,8b-hexahydro- und 1,2,3,4,4a,5a,8a,8b-oktahydro-6h-pyrrolo[3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivate und ihre verwendung zur bekämpfung von endoparasiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |